© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad

More articles/Ad

More articles

  • Saudi Arabia real estate financing company Amlak has announced the first IPO on the Tadawul stock exchange since the onset of the global Covid-19 pandemic.
  • UK listed product inspection company Intertek is looking to sell US private placements, according to sources, as the market struggles to entice companies away from bond issuance and bank lending.
  • The US Federal Reserve deployed another tool from its arsenal yesterday: the ability to purchase individual corporate bonds. There is a strong belief in the markets that the central bank is acting, at least in part, to support equity markets, so why doesn’t it do so openly?
  • Asset managers are set to face bigger demands for equity funding later in the year, despite having already thrown billions at the market as companies attempted to survive the coronavirus pandemic. A source close to BlackRock said it had already committed $18bn-equivalent in equity funding to European companies during the crisis but inflows from US investors will help it and its peers buy into the deals to come.
  • CEE
    The Republic of Belarus is taking a second run at the new issue market after its first round of marketing ran into Covid-19.
  • The Single Resolution Board is asking for new data from banks on their key metrics as of the end of June, with an eye to using the information to tweak their minimum requirements for own funds and eligible liabilities for 2020.